Innovation

The development of the life sciences, the biotechnology and precision medicine requires the collection, preservation, storage and distribution of an exponentially increasing number of biospecimens and products derived from them, the integrity of which must be guaranteed. Cold preservation technologies are simply no longer sustainable to support this development, which represents a major technological, organizational, economic and ecological challenge.

The IMAGENE technology initially designed for the conservation at room temperature of nucleic acids is based on the confinement of samples, previously desiccated, inside stainless and tight metal minicapsules, under an anhydrous and anoxic atmosphere. Thus protected from their alteration factors, these molecules remain of sufficient quality as to be compatible with any type of subsequent analysis and manipulation.
This breakthrough technology makes it possible to preserve nucleic acids of any origin in the very long term, while providing decisive advantages over conventional cold storage methods in terms of safety, storage space, cost, ease of use, automation, transportation and distribution.

Imagene is now successfully extending its technology to the conservation of all biological samples and reagents involved in health improvement, advances in research and environmental protection. In particular, our technology fulfills the requirements of technical performance, efficiency and economic and environmental sustainability for the preservation of blood products, viruses, bacteria, proteins, fluorophores, bioreagents and reaction media.